866-997-4948(US-Canada Toll Free)

Global Antibiotics Market 2017-2021

Published By :

Technavio

Published Date : Sep 2017

Category :

Infectious Disease

No. of Pages : 118 Pages

About Antibiotics

An antibiotic is a chemical compound that kills or slows down the growth of any disease-causing microorganisms such as bacteria, parasite, and fungi but is not effective against viruses and prions. The term "antibiotic" was originally coined to refer to any compound of microbial origin that is antagonistic to the growth of the microbe. Antibiotics act via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis.

Technavios analysts forecast the global antibiotics market to grow at a CAGR of 2.16% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global antibiotics market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Antibiotics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Allergan
GlaxoSmithKline
Merck
Pfizer

Other prominent vendors
Abbott
Achaogen
Actelion Pharmaceuticals
AmpliPhi Biosciences
Aspen Pharmacare
Astellas Pharma
AstraZeneca
Aurobindo Pharma
Baxter
Basilea Pharmaceutica
Bayer HealthCare
Biocon
Bristol-Myers Squibb
Cempra
Cipher Pharmaceuticals
CordenPharma
Chiesi Farmaceutici
Eli Lilly
Exoxemis
F. Hoffmann-La Roche
Flynn Pharma
Incepta Pharmaceuticals
InSite Vision
Insmed
Johnson & Johnson
Humanigen
Kyorin Pharmaceutical
Lupin Pharmaceuticals
Lytix Biopharma
Melinta Therapeutics
Mylan
Nektar
Orchid Pharma
Par Pharmaceutical
Paratek Pharmaceuticals
Pernix Therapeutics
PTC Therapeutics
RedHill
Sagent Pharmaceuticals
Sanofi
Shionogi
Starpharma
Sun Pharmaceutical
Symbiomix
Takeda Pharmaceutical
Tetraphase Pharmaceuticals
Theravance Biopharma
The Medicines Company
Valneva
Wockhardt

Market driver
Rising prevalence of infectious diseases
For a full, detailed list, view our report

Market challenge
Development of antibiotic-resistant strains
For a full, detailed list, view our report

Market trend
Strategic alliances and mergers and acquisitions (M&A)
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Antibiotics: An overview
Introduction
Mechanism of action of antibiotics
General principles for the use of antibiotics
Clinical use of antibiotics
Epidemiology of infections
Application of antibiotics
PART 06: Veterinary drug approval process
Animal antibiotics
NADAs and supplements
ANADAs and supplements
CNADAs
PART 07: Antibiotic resistance: An overview
Cause of antibiotic resistance
Development of antibiotic resistance
Spread of antibiotic resistance
Initiatives to facilitate antibiotic development
PART 08: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 09: Pipeline landscape
Gepotidacin
MK-3415A
Amikacin Inhale
Carbavance
Eravacycline
Plazomicin
Delafloxacin
Solithromycin
ARIKAYCE
Cadazolid
Ozenoxacin
PART 10: Market segmentation by chemical class
Beta-lactams
Macrolides
Quinolones
Others
PART 11: Market segmentation by drug origin
Natural
Semisynthetic
Synthetic
PART 12: Market segmentation by mechanism of action
Bacteriostatic
Bactericidal
PART 13: Market segmentation by application
Antibiotics for human use
Antibiotics for veterinary use
PART 14: Market segmentation by spectrum
Broad-spectrum antibiotics
Narrow-spectrum antibiotics
PART 15: Geographical segmentation
Market overview
Antibiotics market in APAC
Antibiotics market in Americas
Antibiotics market in EMEA
PART 16: Decision framework
PART 17: Drivers and challenges
Market drivers
Market challenges
PART 18: Market trends
Strategic alliances and mergers and acquisitions (M&A)
Patient assistance programs (PAPs)
Increased federal and institutional funding on antibiotic research
PART 19: Vendor landscape
Competitive scenario
PART 20: Key vendor analysis
Allergan
GlaxoSmithKline
Merck
Pfizer1
Other prominent vendors
PART 21: Appendix
List of abbreviations
List of Exhibits
Exhibit 01: Overview of mechanism of action of antibiotics
Exhibit 02: Mechanism of action of antibiotics
Exhibit 03: General principles involved in the use of antibiotics
Exhibit 04: Clinical use of antibiotics for treatment of various common infections
Exhibit 05: Types of HAIs 2016
Exhibit 06: Causes of antibiotic resistance
Exhibit 07: Transfer of antibiotic-resistant strain
Exhibit 08: Development of antibiotic resistance
Exhibit 09: Spread of antibiotic resistance
Exhibit 10: Antibiotic resistance scenario in the US
Exhibit 11: Initiatives to facilitate antibiotic development
Exhibit 12: Global antibiotics market snapshot
Exhibit 13: Global antibiotics market revenue 2016-2021 ($ millions)
Exhibit 14: Opportunity analysis of global antibiotics market
Exhibit 15: Five forces analysis
Exhibit 16: Pipeline landscape of global antibiotics market 2016
Exhibit 17: Key clinical trials
Exhibit 18: Segmentation of global antibiotics market by chemical class 2016
Exhibit 19: Segmentation of global antibiotics market share by chemical class 2016
Exhibit 20: Cephalosporin segmentation by generation of drugs
Exhibit 21: Segmentation Global antibiotics market by drug origin 2016
Exhibit 22: Segmentation of global antibiotics market by mechanism of action 2016
Exhibit 23: Segmentation of global antibiotics market by application 2016
Exhibit 24: Segmentation of global antibiotics market by spectrum 2016
Exhibit 25: Global antibiotics market share by spectrum 2016
Exhibit 26: Global broad-spectrum antibiotics market 2016-2021 ($ millions)
Exhibit 27: Global narrow-spectrum antibiotics market 2016-2021 ($ millions)
Exhibit 28: Segmentation of global antibiotics market share by geography 2016 and 2021
Exhibit 29: Segmentation of global antibiotics market revenue by geography 2016-2021
Exhibit 30: Segmentation of global antibiotics market share by geography 2016-2021 (%)
Exhibit 31: Antibiotics market scenario in different regions
Exhibit 32: Market scenario in APAC
Exhibit 33: Antibiotics market in APAC 2016-2021 ($ millions)
Exhibit 34: Market scenario in Americas
Exhibit 35: Antibiotics market in Americas 2016-2021 ($ millions)
Exhibit 36: Legislation regulating antibiotic use in US
Exhibit 37: Market scenario in EMEA
Exhibit 38: Antibiotics market in EMEA 2016-2021 ($ millions)
Exhibit 39: Antibiotic-resistant strains according to the period of development of resistance
Exhibit 40: Antibiotic drug approvals versus time interval
Exhibit 41: Competitive structure analysis of global antibiotics market 2016
Exhibit 42: Allergan: Key highlights
Exhibit 43: Allergan: Strength assessment
Exhibit 44: Allergan: Strategy assessment
Exhibit 45: Allergan: Opportunity assessment
Exhibit 46: GlaxoSmithKline: Key highlights
Exhibit 47: GlaxoSmithKline: Strength assessment
Exhibit 48: GlaxoSmithKline: Strategy assessment
Exhibit 49: GlaxoSmithKline: Opportunity assessment
Exhibit 50: Merck: Key highlights
Exhibit 51: Merck: Strength assessment
Exhibit 52: Merck: Strategy assessment
Exhibit 53: Merck: Opportunity assessment
Exhibit 54: Pfizer: Key highlight
Exhibit 55: Pfizer: Strength assessment
Exhibit 56: Pfizer: Strategy assessment
Exhibit 57: Pfizer: Opportunity assessment

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *